FCGR2A and COVID-19: The frequency of FcγR-independent, infection-enhancing antibodies to SARS-CoV-2 was determined by measuring the neutralizing or infection-enhancing activities of 1,213 mAbs derived from a previous longitudinal study of B-cell evolution in 8 COVID-19 convalescent donors [22].